Virus-Specific T Cells and CXCL-8 Production in Hepatitis B Infection
Author Information
Author(s): Gehring Adam J., Koh Sarene, Chia Adeline, Paramasivam Komathi, Chew Valerie Suk Peng, Ho Zi Zong, Lee Kang Hoe, Maini Mala K., Madhavan Krishnakumar, Lim Seng Gee, Bertoletti Antonio
Primary Institution: Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore
Hypothesis
The inflammatory cytokine milieu present during HBV infection can license T cells with the ability to produce CXCL-8 or IL-17.
Conclusion
HBV-specific T cells can produce the neutrophil chemokine CXCL-8 during liver inflammation, influenced by the presence of IL-7 and IL-15.
Supporting Evidence
- HBV-specific T cells can produce CXCL-8 but not IL-17 during liver inflammation.
- CXCL-8 production was significantly increased in T cells cultured with IL-7 and IL-15.
- Functional plasticity of T cells was observed, allowing them to adapt their cytokine production based on environmental signals.
Takeaway
In people with hepatitis B, certain immune cells can make a substance that attracts other immune cells to the liver, especially when certain signals are present.
Methodology
The study involved analyzing HBV-specific T cells from patients during different phases of infection and assessing their ability to produce CXCL-8 and IL-17 in response to specific cytokines.
Limitations
The study had a limited number of patients and responses, which may affect the generalizability of the findings.
Participant Demographics
Patients included 12 acute/resolved HBV patients and 18 chronic HBV patients, with a mix of demographics from Singapore.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website